Antares Pharma is the latest pharmaceutical company hoping to profit off the booming testosterone replacement therapy market. The company announced it has submitted an application to the Food and Drug Administration (FDA) for marketing approval for its QuickShot Testosterone therapy designed to boost levels of the hormone in men. QuickShot Testosterone is a drug-device combo that delivers testosterone enanthate through a subcutaneous auto-injector that can be self-administered. It’s also touted to be less painful than intramuscular injections. It uses high spring pressure to deliver the drug through a fine gauge needle. Antares says the delivery system essentially eliminates the risk of ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.